Paul Varki
Chief Legal Officer · Avalo Therapeutics, Inc.
- 2026
- Jun 12, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Varki files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Ryan Sullivan - $3.72M in AVTX purchases and sales in the last 12 months
- Mittie Doyle - $2.98M in AVTX purchases and sales in the last 12 months
- Jonathan Goldman - $163K in AVTX purchases and sales in the last 12 months
- Mitchell Chan - $72K in AVTX purchases and sales in the last 12 months
- Jennifer Riley - $52K in AVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Varki?
Paul Varki is a corporate insider, tracked as Chief Legal Officer of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Paul Varki last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 4 filings going back to 2026.
Has Paul Varki been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.51M) across all tracked filings.
